Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

TNF-alpha inhibitors can cause various immune-related skin issues.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Higher inflammation markers are linked to more severe alopecia areata.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Certain immune cells help hair growth by regulating iron in the skin.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

The new skin model can predict how chemicals might cause skin allergies.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Understanding patients' views on their illness can help improve their disease management.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.